Virus Filtration Market Report 2025

The virus filtration market size has grown rapidly in recent years. It will grow from $5.41 billion in 2024 to $6.03 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rise in biopharmaceutical production, growing incidence of viral contaminations, global expansion of biopharmaceutical companies, awareness of viral safety, focus on monoclonal antibody production, demand for single-use systems, increased biomanufacturing capacities, integration of continuous manufacturing.

The virus filtration market size is expected to see rapid growth in the next few years. It will grow to $9.88 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growth in vaccine production, preparedness for emerging viral threats, expansion of cell and gene therapy, increasing demand for biosimilars, development of high-throughput systems, focus on point-of-use filtration, continuous improvement in product design, flexibility in bioprocessing workflows. Major trends in the forecast period include technological convergence with nanotechnology, integration of artificial intelligence (ai), sustainable filtration technologies, customized filtration solutions, disposable filtration technologies, integration of automation, increased R&D investments, technological partnerships and collaborations.

The escalation in chronic diseases serves as a significant impetus behind the expansion of the virus filtration market. Chronic illnesses, persisting for a year or longer and often necessitating continual medical attention or impacting daily activities, drive the demand for virus filtration systems. These systems play a pivotal role in averting infectious diseases and chronic conditions by effectively removing viruses, contributing to the market's growth. For instance, statistics from the World Health Organization (WHO) published in September 2022 highlight that noncommunicable diseases (NCDs) lead to approximately 41 million deaths annually, accounting for 74% of global deaths. Among NCDs, cardiovascular diseases claim a significant toll, resulting in 17.9 million deaths annually. The increasing prevalence of cardiovascular conditions is anticipated to further propel the virus filtration market's growth.

The rising demand in the pharmaceutical industry is anticipated to drive the growth of the virus filtration market in the future. The pharmaceutical industry, a segment of the healthcare sector, focuses on the research, development, production, and marketing of drugs and medications for medical treatment. Virus filtration plays a crucial role in producing biopharmaceuticals, vaccines, and other advanced therapies, ensuring that safe, effective, and high-quality pharmaceutical products reach patients. For instance, a May 2024 report from IQVIA Inc., a U.S.-based pharmaceutical company, indicated that overall spending growth in the U.S. medicine market reached $435 billion at the net price level in 2023. By 2028, total net spending on medicines is projected to increase by $127 billion compared to 2023, driven by volume growth and the adoption of innovations, although this will be partially offset by factors leading to lower prices, such as patent expirations and legislative impacts. Therefore, the increasing demand in the pharmaceutical industry is propelling the growth of the virus filtration market.

The upsurge in global research and development (R&D) expenditures is poised to propel the virus filtration market in the forecast period. Governments worldwide are augmenting their R&D budgets to position their countries as advanced scientific hubs. These increased allocations aim to foster innovation in healthcare systems, thereby driving the expansion of virus filtration solutions. For instance, in March 2022, the UK government unveiled its largest-ever R&D budget of £39.8 billion ($47.8 billion) to elevate the nation as a science powerhouse. The budgetary allotments, disbursed across the Department for Business, Energy, and Industrial Strategy’s partner organizations, are expected to rise by 33% annually by 2024-2025. Consequently, the surge in global R&D expenditure is set to drive growth within the virus filtration market.

Technological advancement stands out as a pivotal trend driving innovations within the virus filtration market. Key industry players are intensively focused on developing cutting-edge technological solutions to solidify their market presence and offer enhanced protection against airborne viruses. An illustrative example of this trend is Integrated Viral Protection (IVP), a US-based technology startup that introduced an advanced airborne virus filtration unit at CES 2022, a prominent tech event in Las Vegas, USA. This cutting-edge unit is designed to eradicate airborne viruses, including sub-micron variants causing COVID-19, anthrax spores, and allergens, in a single pass. It leverages IVP's patented 'catch and kill virus' technology, which effectively neutralizes airborne viruses, enhancing safety and mitigation measures against various infectious agents.

Major companies in the virus filters market are concentrating on innovating products through technology, such as NanoStrike technology, which is a groundbreaking method of air disinfection. This technology effectively bursts airborne pathogen cells, rapidly inactivating them to mitigate the risk of infection, potentially aiding in the prevention of hospital-acquired infections by lowering the microbial load in the air. For example, in March 2022, WellAir, a U.S.-based health technology company specializing in indoor air disinfection solutions, introduced the Defend 400, which utilizes NanoStrike technology. This air cleaning device is CE marked and demonstrates 99.9% effectiveness in inactivating airborne pathogens, including the SARS-CoV-2 proxy virus (MS2 Bacteriophage), MRSA, bacteria, and fungi, while also purifying the air of particulate matter, volatile organic compounds, gases, and odors.

Major companies operating in the virus filtration market are Merck & Company Inc., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International Inc., Sartorius AG, Asahi Kasei Medical Co. Ltd., WuXi AppTec, Danaher Corporation, Sigma-Aldrich Corporation, Pendotech, Purafil Inc., Parker Hannifin Corporation, Eaton Corporation, Freudenberg Group, Entegris Inc., Meissner Filtration Products Inc., Koch Membrane Systems Inc., Graver Technologies LLC, Amazon Filters Ltd., Cobetter Filtration Equipment Co. Ltd., Sterlitech Corporation, Membrane Solutions LLC, Advantec MFS Inc., GVS Group, Porvair Filtration Group.

North America was the largest region in the virus filtration market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virus filtration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virus filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Virus filtration is a method employed to physically remove potential viruses from manufacturing process streams, serving as a crucial step in ensuring the purity of medicines. These filters act as a primary defense against the introduction of adventitious viruses into this important category of pharmaceuticals. What sets virus filters apart is that their manufacturers have rigorously evaluated and optimized their robustness and efficiency in virus removal performance. Additionally, they have developed integrity tests correlated to virus removal.

The main types of virus filtration include kits and reagents, services, filtration systems, and other related categories. Kits are sterile tubing systems designed for the transfer of radioactive proteins between a labeling (reaction) vessel and a purification column, facilitated by peristaltic pumps. Reagents, on the other hand, are substances or compounds that can facilitate a reaction, and they find wide application in various tests. In the context of virus filtration, reagents are integral components of test kits. The use of virus filtration extends across pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Its applications span diverse areas such as medical devices, water purification, air purification, biologicals, vaccines and therapeutics, blood and blood products, as well as cellular and gene therapy products.

The virus filtration market research report is one of a series of new reports that provides virus filtration market statistics, including virus filtration industry global market size, regional shares, competitors with a virus filtration market share, detailed virus filtration market segments, market trends and opportunities, and any further data you may need to thrive in the virus filtration industry. This virus filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virus filtration market consists of revenues earned by entities by providing virus filtering services to effectively remove viruses in various processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The virus filtration market also includes sales of filters and systems used to remove viruses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.